- Home
- VCYT vs NVG Comparison
VCYT vs NVG Comparison
Compare VCYT & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VCYT | NVG |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.7B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | VCYT | NVG |
|---|---|---|
| Price | $44.42 | $12.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $44.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 574.7K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.65% |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.76 | N/A |
| Revenue Next Year | $12.35 | N/A |
| P/E Ratio | $125.91 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.61 | $11.50 |
| 52 Week High | $50.71 | $13.59 |
Technical Indicators
Market Signals| Indicator | VCYT | NVG |
|---|---|---|
| Relative Strength Index (RSI) | 70.11 | 50.46 |
| Support Level | $41.03 | $12.37 |
| Resistance Level | $46.24 | $12.78 |
| Average True Range (ATR) | 1.95 | 0.10 |
| MACD | 0.49 | -0.01 |
| Stochastic Oscillator | 81.06 | 63.08 |
Price Performance
Historical ComparisonAbout VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.